Skip to main content
Equibles

BRIDGEWAY CAPITAL MANAGEMENT, LLC

Position in LFCR — Lifecore Biomedical, Inc. De

CIK 1107261 HOUSTON, TX
Back to LFCR Full portfolio

Position in LFCR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$324,450
+$94,554 QoQ
Shares Held
61,800
0.0% QoQ
Ownership
0.163%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#33
of 98 holders
Holding Since
Jun 2020
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LFCR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $34,784,557 across 16 Drug Manufacturers - Specialty & Generic names. LFCR ranks #11 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PCRX
Pacira BioSciences, Inc.
 411,373 $10,436,533
2 PRGO
PERRIGO Co plc
 830,134 $8,625,092
3 AMPH
Amphastar Pharmaceuticals, Inc.
 298,954 $6,032,891
4 AMRX
Amneal Pharmaceuticals, Inc.
 106,449 $1,842,632
5 IRWD
Ironwood Pharmaceuticals Inc
 389,793 $1,641,028
6 INDV
Indivior Pharmaceuticals, Inc.
 35,000 $1,436,050
7 UTHR
UNITED THERAPEUTICS Corp
 2,620 $1,419,594
8 BIOA
BioAge Labs, Inc.
 42,000 $1,029,420

All Filings in LFCR

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $324,450 61,800
2026-03-31 $229,896 61,800
2025-12-31 $505,524 61,800
2025-09-30 $454,848 61,800
2025-06-30 $501,816 61,800
2025-03-31 $435,072 61,800
2024-12-31 $585,484 78,800
2024-09-30 $379,117 76,900
2024-06-30 $394,497 76,900
2024-03-31 $408,339 76,900
2022-12-31 $356,400 55,000
2022-09-30 $488,950 55,000
2022-06-30 $797,600 80,000
2022-03-31 $926,400 80,000
2021-12-31 $1,165,500 105,000
2020-09-30 $145,800 15,000
2020-06-30 $119,400 15,000